Health condition
Skull base tumours
Skull base tumours - benign and malignant - grow in the anatomically dense floor of the skull among cranial nerves and major vessels; management is by dedicated multidisciplinary teams and ranges from observation to combined surgery and precision radiotherapy.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
The category spans meningiomas, schwannomas, pituitary tumours, chordomas and sinonasal cancers
-
Symptoms map to cranial nerves: double vision, facial numbness, hearing loss, swallowing difficulty
-
Many benign skull base tumours are safely watched with serial imaging
-
Skull base MDTs combine neurosurgery, ENT, ophthalmology and radiation oncology
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
The skull base is the body’s most crowded square inch: twelve pairs of cranial nerves, the carotid and vertebral arteries, the brainstem and the pituitary all thread through it. Tumours here - most commonly benign meningiomas and schwannomas, less commonly aggressive cancers - produce slowly progressive, localising symptoms, and their discovery frequently follows a scan for something else entirely. The first decision is whether anything need be done at all.
Diagnosis and treatment routes
When treatment is warranted, the toolkit is deliberately layered: endoscopic and open microsurgical approaches designed around nerve preservation, stereotactic radiosurgery for small or residual tumours, fractionated and proton radiotherapy where structures are exquisitely sensitive, and staged strategies that accept planned residual tumour rather than trade it for disability. Choosing among these depends heavily on institutional experience - the strongest argument for assessment at a recognised skull base unit. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant neurosurgeon. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Skull base tumours.
Quick, plain-English answers to what people ask us most.
-
What does skull base tumours mean?
Skull base tumours is a term used for a cancer or cancer-related condition affecting a specific tissue or organ. The exact nature, behaviour and severity vary from person to person, which is why diagnosis and staging by a specialist team are essential.
-
What are the risk factors for skull base tumours?
The exact cause is often not fully understood, though risk can be influenced by a combination of genetic factors, age, lifestyle factors, and in some cases exposure to specific triggers. Many people affected have no identifiable single cause.
-
What are the symptoms of skull base tumours?
Symptoms depend on where it is and how advanced it is, and can include a new lump, unexplained pain, unexpected weight loss, fatigue, or changes specific to the affected area. Some cases are picked up incidentally on scans before symptoms appear.
-
How worried should I be about skull base tumours?
This depends heavily on the type, stage and how it responds to treatment — some cases are highly treatable, especially when caught early, while others need more intensive management. Your oncology team will give you a personalised assessment rather than a generic answer.
-
Is skull base tumours hereditary or genetic?
This depends on the specific condition — some cases have a genetic or familial component, while others are linked more to environmental, lifestyle or other health factors. If you have a relevant family history, it's worth mentioning to your clinician.
-
Is there a cure for skull base tumours?
Outcomes depend on the type and stage, but many cases respond well to treatment, particularly when identified early. "Cure" isn't always the right framing for every case — your team will discuss realistic goals, whether that's cure, remission, or long-term control.
-
How is skull base tumours treated?
Treatment is tailored to the type and stage, and may include surgery, radiotherapy, chemotherapy, targeted or immunotherapy, or a combination, decided by a multidisciplinary specialist team.
-
What is the long-term outlook for skull base tumours?
This varies significantly by type and stage, and your specialist team will give you a personalised sense of prognosis and expected timelines for treatment and follow-up rather than a general figure.
-
When should specialist referral be considered for skull base tumours?
Specialist referral is appropriate as soon as this is suspected or confirmed, so that staging and a treatment plan can begin without delay — earlier specialist input generally supports better outcomes.
-
When should I see a doctor about skull base tumours, and how quickly can I be seen privately?
See a doctor if symptoms are persistent, worsening, or affecting your daily life — earlier assessment generally leads to better management. NHS routine referrals for this kind of concern often take 20–45 weeks or longer depending on the area, while a private consultant can typically see you within about 2 weeks, with faster access to scans and specialist opinion.